Display options
Share it on

Res Rev J Hosp Clin Pharm. 2017 Jul;3(2):5-6. Epub 2017 Jun 08.

Immune Check Point Inhibitors in Cancer Therapy: Beware of "Friendly Fire" Effect.

Research & reviews. Journal of hospital and clinical pharmacy

Anuhya Kommalapati, Shanaz Sikder, Sri Harsha Tella

Affiliations

  1. Department of Internal Medicine, Washington Hospital Center, Washington DC, USA.
  2. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, USA.
  3. Eunice Kennedy Shriver National Institutes of Child Health and Human Development (NICHD), NIH, USA.

PMID: 29291253 PMCID: PMC5744671

[No abstract available.]

References

  1. Ann Oncol. 2017 Aug 1;28(8):2034-2038 - PubMed
  2. Ther Adv Respir Dis. 2016 Jun;10 (3):183-93 - PubMed
  3. Ann Transl Med. 2016 Jul;4(14):273 - PubMed
  4. JAMA Oncol. 2016 Oct 1;2(10 ):1346-1353 - PubMed
  5. Trends Immunol. 2014 Jul;35(7):290-8 - PubMed
  6. Curr Med Chem. 2017 Apr 07;: - PubMed
  7. Future Oncol. 2016 Feb;12 (3):413-25 - PubMed
  8. Immunotherapy. 2016 May;8(5):665-74 - PubMed
  9. Curr Opin Neurol. 2016 Dec;29(6):806-812 - PubMed
  10. Cancer Treat Rev. 2016 Mar;44:51-60 - PubMed
  11. Crit Rev Oncol Hematol. 2014 Jan;89(1):140-65 - PubMed
  12. Future Oncol. 2015;11(17):2471-84 - PubMed

Publication Types

Grant support